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Khorozan-Razavi eyaleti, Kuzey Doğu İran’da yer alan, anthroponotik kutanöz leishmaniasis (AKL’nin sebep olduğu Leishmania 
tropica) ve zoonotik kutanöz leishmaniasis (ZKL’ye sebep olan Leishmania major) için endemik bir bölge niteliğindedir. Bu çalışmada 
klinik önem bakımından bazı şehirler AKL olarak nitelendirilmesine karşılık bazı şehirler ZKL olarak tanımlanmıştır.
Bu araştırma, kutanöz leishmaniasis (KL) olarak teşhis edilmiş hastalardan elde edilen örneklerin direkt mikroskobik bakıyla 
teşhisleri ile ELISA, elektroforez, izoenzim, RAPD PCR ve PCR yardımı ile Meşhed’te gerçekleştirilmiştir. Bu araştırma aynı 
zamanda Khorozan-Razavi eyaletinde sadece PCR kullanılarak yapılan KL örneklerini de içerir. Yapılmış olan bu çalışmanın 
sonuçları araştırma yapılan şehirlerin çoğunda Leishmania tropica ve Leishmania major’un KL enfeksiyonlarına sebep olduğunu 
göstermiştir. Bizim çalışmalarımızda AKL olgularının yaygın olarak görüldüğü bölgelerde Leishmania major’a rastlanırken, ZKL 
olgularınun yüksek oranlarda görüldüğü yerlerde de Leishmania tropica saptanmıştır. Bu dağılım Khorosan-Razavi eyaletindeki 
Leishmania’nın sebep olduğu olduğu hastalıkların dağılımını göstermektedir.
Anahtar Kelimeler: Kutanöz leishmaniasis, Leishmania major, Leishmania tropica, moleküler ve immünolojik teknikler, 
Khorasan-Razavi bölgesi
The province of Khorasan-Razavi in the North East of Iran is an endemic area for anthroponotic cutaneous leishmaniasis (ACL 
caused mainly by Leishmania tropica) and zoonotic cutaneous leishmaniasis (ZCL caused mainly by Leishmania major). Based on 
clinical signs, some cities were considered as ACL foci while others were considered to be endemic for ZCL.
This paper reviews studies performed on patients diagnosed with cutaneous leishmaniasis (CL) via the use of direct slide 
examination, ELISA, electrophoresis isoenzyme, RAPD PCR and PCR in Mashhad; the study also includes cases of CL in other 
cities of the Khorasan-Razavi province where only PCR used as a diagnostic tool. The data show that both Leishmania tropica and 
Leishmania major caused CL in most of the cities investigated. Our review shows that Leishmania major was found in areas where 
ACL is prevalent and Leishmania tropica was observed in areas with high incidence of ZCL. This distribution represents a major 
change in the epidemiological pattern of Leishmania in the Khorasan-Razavi province.
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INTRODUCTION
Leishmaniasis is a vector-borne disease caused by protozoa 
belonging to the Leishmania genus. Cutaneous leishmaniasis (CL) 
is the most common form of leishmaniasis in the Middle East. CL is 
transmitted by the bite of sand flies (a subfamily of Phlebotomine) 
(1). Humans and dogs are the main reservoirs of Leishmania 
tropica causing anthroponotic cutaneous leishmaniasis (ACL) with 
chronic, dry form, delayed ulceration and plentiful amastigotes. 
Wild rodents have an important role as reservoirs of Leishmania 
major causing zoonotic cutaneous leishmaniasis (ZCL) with acute, 
moist form, early ulceration and few amastigotes (2). 
According to the World Health Organization (WHO) approximately 
0.6-1 million new CL cases are estimated to occur worldwide 
annually; two-thirds of cases are in Afghanistan, Algeria, Brazil, 
Colombia, Iran and the Syrian Arab Republic (3).
Over the last decades a significant increase in the number of cases 
of leishmaniasis has been reported worldwide (4). This rise may 
be due to behavioral and environmental changes such as new 
settlements, deforestation, large migrations from rural to urban 
areas, fast and unplanned urbanization, building of dams and new 
irrigation projects that increase exposure of humans to sand fly 
vectors (5). 
 Prevention and control programs are directly dependent on 
targeting the right species of the parasite (6). However, the species 
of Leishmania that cause different forms of CL are morphologically 
similar, making differentiation between species by microscopy 
alone impossible. For this reason, alternative methods such 
as isoenzyme analysis and immunological approaches such as 
fluorescent dye-conjugated monoclonal antibodies have been 
recently used for identifying Leishmania spp. (4). Furthermore, 
molecular methods based on PCR have also been used routinely 
by many laboratories to detect Leishmania in carrier hosts and to 
map parasite reservoirs (7,8). 
Several studies have been performed in the Khorasan-Razavi 
province to diagnose leishmaniasis from observation of 
clinical symptoms (9). However, information on the incidence 
of leishmaniasis based on new immunological or molecular 
methods is poor in this area. To improve diagnosis and eventually 
approaches to treatment, the University of Medical Sciences in 
Mashhad performed immunological and molecular studies to 
identify those Leishmania species that cause CL and to design 
plans for targeted epidemiological intervention in endemic cities 
of the Khorasan-Razavi province.
METHODS
This paper reviews clinical and epidemiological studies on 
leishmaniasis performed in the province of Khorasan-Razavi. The 
paper briefly reviews current global and Iranian epidemiological 
data on CL. The review compares previous data on CL in different 
cities of Khorasan-Razavi province with current epidemiological 
data. The paper is based on PubMed and Google Scholar literature 
searches from 1979 to 2018 using the following keywords: 
“CL”, “prevalence OR epidemiology”, “causative agents of CL 
OR molecular detection of Leishmania spp.”. These key words 
were then, combined with “Iran” and “Razavi Khorasan OR 
Khorasan-Razavi province”. Both papers in English and Persian 
were considered. We also considered data from graduate theses 
on epidemiology of CL and on molecular detection of Leishmania 
species in Khorasan-Razavi.
RESULTS
Epidemiology of Cutaneous Leishmaniasis in Iran 
CL is one of the 10 most important parasitic diseases in tropical 
regions of the world, being present in all continents except for 
Australia (10). Investigations on various aspects of this disease 
have been prompted and supported by WHO and global burden of 
disease (GBD). According to GBD, the prevalence of CL has risen 
from 2.1 million in 2002 to nearly 4 million cases in 2015 (11-13). 
The number of individuals with latent CL is estimated at about 
12-20 million (10).
Disability-adjusted life years (DALY) due to CL is estimated at 
about 2 million years. Considering that only patients who are 
positive for Leishmania spp. are included in the DALY formula, 
and the psychosocial impact of scars due to CL (approximately 40 
million cases) has not been taken into account, the real DALY is 
likely to be higher than the current estimated figure (13). 
CL is the second most prevalent arthropod-transmitted disease 
in Iran (14). Despite the attempts of Iranian health officers to 
prevent and control leishmaniasis, the disease is still spreading 
and new foci of CL are reported every year. For example, 17 
previously infection-free provinces of Iran are now endemic for 
leishmaniasis (15).
According to the data published by the Iranian Ministry of Health 
in 2011, about 20000 new CL cases are reported in Iran annually, 
while the actual number of patients with CL is estimated to be 
four to five-fold higher. Patients with either moist or dry lesions 
are observed in both rural and urban areas in Iran (16). The rural 
form or ZCL with moist lesions is observed in 15 provinces of 
Iran including Isfahan, Sarakhs, Lotfabad, Khuzestan, Kashmar, 
Kashan, Dehloran and Damghan, whereas the urban form or ACL 
with dry lesions has been reported in Tehran, Shiraz, Mashhad, 
Neishabur, Kerman, Bam, Rafsanjan and Khomeyn Shahr (16,17).
Epidemiological studies in Iran indicate more than 90% of CL 
cases occur in 88 cities and transmission occurs in 17 provinces 
in Iran with a prevalence rate ranging from 1.8% to 37.9% (18). 
Isfahan, Fars, Bushehr, Ilam, Khuzestan, Yazd, Semnan, Kerman, 
and Khorasan were high incidence areas between 1983-2013. 
A lower burden of infection was observed in Gilan, Kurdistan, 
Azerbaijan-West, Ardabil, Tehran, Qazvin, Hamedan, Azerbaijan-
East, Kermanshah, Kohgiloyeh-Boyer-Ahmad, Lorestan, Markazi, 
and Chaharmahal- Bakhtiari. The last data about number of CL 
patients in different province of Iran during 2011-2013 has been 
shown in Table 1 (16,19). 
The incidence rate of CL follows a cyclical pattern of rise and 
fall between 20 to 40 cases per 100,000 people and a periodic 
trend lasting 5-6 years, which shows the limited effect of control 
measures that are transiently implemented in response to 
episodes of increased incidence of the disease (20).
Therefore, improved and permanent measures for 
epidemiological control of CL in Iran must be rationally designed 
and implemented with the participation of health authorities and 
relevant governmental agencies in order to reduce the incidence 
and prevalence of CL (16).
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The Epidemiology of Cutaneous Leishmaniasis in 
Khorasan-Razavi 
The present study reviews the CL status in different districts of 
Khorasan-Razavi.
CL has been present for a long time as an important endemic 
disease in the Khorasan-Razavi province in the North East of Iran 
(21). The Khorasan-Razavi province has the highest prevalence of 
CL infection in Iran (16). Since this province has shared borders 
with Afghanistan and Turkmenistan, changes in the incidence rate 
and epidemiological pattern of CL might be linked to neighboring 
countries. In fact, gerbil reservoirs and vectors of ZCL have been 
confirmed along the border between Iran and Turkmenistan as 
well as in the Afghan city of Heart which is in an area endemic 
for ACL and close to Iran (22,23). Most of infected domestic and 
wild Canidae have been affected by L. infantum in Iran (24,25). 
However, infections with with L. tropica were reported from 
canidae in Syria, Morocco, and Israel (26-30). Dogs are therefore 
a secondary reservoir host for L. tropica and for its transmission 
to human.
Mashhad, the second most populous city in Iran and the capital of 
Khorasan-Razavi province is located in the North East of Iran and 
close to the border with Turkmenistan and Afghanistan. Mashhad 
is one of the main endemic areas for ACL. During the last two 
decades, CL cases have significantly risen in Mashhad causing 
concerns in the health authorities (6). According to the Khorasan-
Razavi Health Center in 2001, the highest prevalence of CL was 
seen in the region of Ab-o-Bargh, where population density, stray 
dogs, cultural and economic poverty in suburbs are considered as 
the main socio-epidemiological risk factors. Haj Norouz is another 
high disease area in Mashhad due to predisposing factors such as, 
the existence of building debris, old building with wooden roofs 
and areas where waste material is accumulated (17).
Neishabur, the former capital of Khorasan-Razavi province, has 
also been considered as an important endemic city for ACL with 
the rate of infection in some regions such as Sarcheshmeh and 
Kariz-no being higher than in others (5). ACL is present in the city 
of Sabzevar in Khorasan Razavi, while the disease has not been 
detected in Mazinan in Sabzevar (13).
Sarakhs in the North East of Iran is a high prevalence region 
for L. major. It is possible that its location on the Silk Road, the 
proximity to Turkmenistan and the high volume of commercial 
traffic could underpin the increased incidence of leishmaniasis 
in this city (31). Torbat-e Jam is another county where many 
CL cases have been observed annually. This district is located in 
the South West of Mashhad and north of Taybad, West of the 
Afghanistan border (32,33).
Based on the clinical appearance of CL lesions, it has been inferred 
that the patients in the towns of Chenaran and Quchan probably 
suffer from L. tropica, while L. major has been known as dominant 
strain of CL in Dargaz and Kalat, that are located in the North 
and North East, respectively. It is noticeable that Quchan, in 
the North East of Iran, has a border with Turkmenistan and is 
connected by road with Chenaran city half way to Mashhad.
Based on the clinical appearance of CL lesions, several 
investigations have indicated that Torbat-e Heydarieh and 
Fariman, in the South of Mashhad, are endemic for L. tropica. 
However, conclusive data on the identification of Leishmania 
species in this area based on immunological or molecular tools is 
still lacking. Since these towns are situated on the way of travel to 
Mashhad, accurate identification of CL agents can be effective to 
determine the control and prevent strategies (34). 
It is still unclear which parasite species cause CL in the cities of 
Gonabad, Kashmar and Bardaskan in the southwest and Khaf and 
Taybad districts in the South East of Khorasan-Razavi province.
Identification of the Parasite Species Responsible for 
Cutaneous Leishmaniasis in Endemic Areas of North 
East Iran 
The identification of Leishmania species is essential to monitor 
the spread of the disease as well as to design and implement 
effective control methods. Since control and prevention of ZCL 
and ACL are different, several studies have focused on the correct 
identification of Leishmania species in Khorasan-Razavi during the 
past two decades (6).
Mohajery et al. (35), used isoenzyme electrophoresis for the 
identification of Leishmania spp. and showed that Mashhad is 
the main focus for L. tropica, but L. major was present in other 
regions, particularly in the suburbs.
In another study, Valizadeh et al. determined the causative 
species of Leishmania in 72 cases of CL in Mashhad using an 
ELISA method based on species-specific monoclonal antibodies. 
52 cases were identified as L. tropica, 16 as L. major and 4 cases 
were caused by unidentified species (35).
Table 1. The number of CL patients in different province of 
Iran during 2 years (2011-2013) (16)
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Between 2002 and 2005, Hajjaran et al. (4) collected 87 parasite 
samples from patients with CL who were referred to Mashhad 
health centers and determined the species of Leishmania by 
RAPD-PCR. 94.2% of the isolates were identified as L. tropica, 
whereas 5.8% were identified as L. major.
Mahmoudi in 2005 used PCR to determine the causative agent 
of CL in Mashhad and demonstrated L. major in 2/21 cases and 
the other samples were identified positive for L. tropica (36). 
Similar results were reported by Fata et al. (37) in 2007 using the 
Whatman paper and PCR methods. 
The epidemiological pattern of leishmaniasis in Mashhad and the 
increased incidence of CL in Khorasan-Razavi prompted further 
studies to identify the main causative agents of CL in other 
counties of this province. 
A study including 84 CL patients in the county of Sabzevar 
in 2006-2007 detected 32 cases of L. tropica and 52 cases of L. 
major. Another study on 52 patients in Neishabur using RAPD-
PCR only detected L. tropica (38,39). The cities of Sabzevar and 
Roudab were the foci in the county of Sabzevar where L. tropica 
was detected, whereas the cities of Hokm Abad, Ghezelgharshi, 
Joghatay and Mohamad Abad were endemic foci of both L. tropica 
and L. major (39).
Molecular investigations by Hossein Farash et al. and Saadabadi 
et al. (40) on 144 patients with CL identified only L. tropica in the 
districts of Torghabeh-Shandiz (2010) and Kharv (2007), which 
are close to Mashhad and Neishabur, respectively (6,40). Pagheh 
et al. reported similar findings in 2013 in Torbat-e Jam in a cohort 
of 504 patients with Leishmania lesions (32).
In 2013, Shamsian et al. (31) identified L. tropica in 12 patients 
and L. major in 52 cases in Sarakhs that had previously been 
known as an area where L. major was prevalent as the cause of 
ZCL (31).
Despite Khaf and Taybad had been considered as ACL foci (L. 
tropica) until 2015, Abdolmajid et al. (41)  found 20 cases for L. 
major among 66 positive persons with CL by PCR method (41). 
Using a similar method between 2015 and 2017, Shamsian et 
al. diagnosed 7 patients with ZCL out of 60 subjects with CL in 
Torbat-e Heydarieh and 16 with L. major out of 84 patients from 
Kashmar (11 cases), Bardaskan (2 cases) and Gonabad (3 cases) 
(34,42).
On the contrary, using PCR in 2015 Fata et al. (36) demonstrated 
22 patients infected by L. tropica from 85 cases of CL patients in 
the ZCL foci of Dargaz and Kalat 2015 (29).
13 cases of L. tropica out of 42 patients were diagnosed by 
Shamsian et al. (43) in Fariman, another known focus for L. major, 
in 2017.
Finally, Shamsian et al. (44) found 29 out of 86 samples positive 
for L. major in CL infected patients in Quechan and Chenaran 
despite L. tropica had been considered as the only causative 
species of CL in this area.
It is noticeable that all the studies reported here, except for the 
ones in Neishabur, Kharv, and Torbat-e Jam, were performed 
using the same PCR protocol and same primers that give a 615 
bp band for L. major and a 744 bp band for L. tropica (Figure 1,2). 
These studies are therefore directly comparable (6).
DISCUSSION
The global epidemiology of CL has changed, mainly due to 
population movements, individual risk factors and environmental 
changes. CL is one of emerging parasitic diseases in recent years, 
posing a public health problem in many parts of the world and is 
widespread in Iran (39,40). The epidemiology of CL has changed 
in the past two decades in Iran and both L. tropica and L. major 
have being present in Khorasan-Razavi province (17,45).
The first step in any control and prevention program for 
leishmaniasis is the identification of the infectious agents, 
reservoirs and vectors (35). In recent years, many studies have 
been conducted in Khorasan-Razavi province with the aim to 
refine the immunological and molecular diagnosis of the causative 
Leishmania species (4,6,34,35,39-42,46).
The aim of this review was to design a new epidemiological picture 
of CL, using data from several studies performed in Khorasan-
Razavi province to identify the boundary shifts for causative 
agents of CL during a twenty-year period as the basis to new 
insights for control and prevention measures.
The investigations carried out in Mashhad demonstrated that 
ACL and ZCL co-exist. Furthermore, L. tropica has been known 
the dominant agent causing CL in this city (4,35,37,46). Mashhad 
is the main focus for ACL, but also is a center for L. major, 
particularly in suburbs.
Sabzevar, has two foci of CL, one with dry lesions and the other 
consisting of patients with wet lesions. Until now Sabzevar has 
been known just as an ACL focus while now both forms (ACL and 
ZCL) of the disease have been found to exist at this location (39). 
These epidemiological changes may be due to migration of 
Figure 1. The percentage of Leishmania species frequency in 
different districts of Khorasan-Razavi
Figure 2. Cutaneous leishmaniasis map of Razavi Khorasan 
province in 2017
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people from neighboring countries such as Afghanistan and 
Iraq, rural to urban fluxes which provide suitable conditions for 
transmission, piling of building debris and litter near residential 
areas, which lead to expansion of vector reservoirs for both 
species. Agriculture also causes an increase of L. major reservoirs 
and vector population. Moreover changes in the climate and in 
people lifestyles or the lack of immunity in people who immigrate 
to endemic areas are other risk factors that can increase the 
incidence of CL in a paerticular area (19,34,35). Similar reasons 
for the epidemiological changes listed above are likely to underpin 
the variations in the distribution of Leishmania species observed 
in Torbat-e Heydarieh, Bardaskan, Kashmar, Khaf, Taybad, 
Quechan and Chenaran (34,41,42,44).
The presence of both L. tropica and L. major species as causes of CL 
in Sarakhs might be related to its location near an international 
railroad and in proximity to the border with Turkmenistan; 
increased movement of people through this region since 2013 is 
likely to be an additional factor in the observed epidemiological 
pattern of leishmaniasis (31). The diffusion of L. tropica in 
Fariman, Kalat, and Dargaz could result from changes in health 
programs to control the vectors and development of industry and 
tourisms. Therefore, some of labor migrants or travelers who are 
infected by L. tropica could be reservoir hosts for this emerging 
agent (36).
Torbat-e Jam, Neishabur, Kharv, Torghabeh-Shandiz are located 
in the vicinity of Mashhad and similarly to Mashhad have been 
considered as ACL foci (6,32,39,40). Despite all cases in these 
regions were identified as L. tropica with molecular method, 
the number of lesions, their morphological characteristics and 
the season of occurrences in some patients corresponded to the 
characteristics typical of L. major infections; therefore, it may be 
desirable to extend and refine the examinations to ensure that 
cases of ZCL do not go undetected.
CONCLUSION 
CL is a major health problem in Khorasan-Razavi province where 
most of the regions are affected by both L. tropica and L. major 
species. 
Several measures can be suggested to reduce the incidence 
of the disease in the urban endemic areas. Classes on health 
education for inhabitants, reducing the numbers of stray dogs, 
identification and urgent treatment of clinical cases could be 
effective. Reduction in rodent and carrier population, removal of 
waste and environmental modifications should be considered as 
key health policies in areas with L. major (6,19).
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